QR Code

Use of continuous glucose monitoring in non-intensively managed type 2 diabetes: a Saudi Arabian consensus

BackgroundSaudi Arabia has one of the highest prevalences of diabetes globally, with 16.4% of the population living with type 2 diabetes (T2D). While continuous glucose monitoring (CGM) is widely used for patients with type 1 diabetes, evidence suggests its benefits can extend to patients with T2D....

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Mohammed Almehthel, Abdulghani Al-Saeed, Fahad Al-Sabaan, Faisal Al-Malky, Hawazen Zarif, Lamya Al-Zubaidi, Mohammed E. Al-Sofiani, Omar Abdulaal, Reem Al Argan, Saud Al Sifri, Turki Al-Harbi, Raed Aldahash
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Frontiers Media S.A. 2026-01-01
Rangatū:Frontiers in Endocrinology
Ngā marau:
continuous glucose monitoring
non-intensive
oral antidiabetics
Saudi Arabia
type 2 diabetes
Urunga tuihono:https://www.frontiersin.org/articles/10.3389/fendo.2025.1738398/full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite